Search filters

List of works by Jerry Bagel

A Prospective, Open-Label Study Evaluating Adjunctive Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Psoriasis Patients With Inadequate Response to Biologic Therapy

scientific article published on 01 August 2018

A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial

scientific article published on 30 December 2019

A multicenter dose-escalation trial with denileukin diftitox (ONTAK, DAB389IL-2) in patients with severe psoriasis ⬇️

scientific article published on 01 December 2001

A review of phototherapy protocols for psoriasis treatment ⬇️

scientific article published on March 22, 2011

Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial

scientific article published on 20 December 2010

Adalimumab plus narrowband ultraviolet B light phototherapy for the treatment of moderate to severe psoriasis

scientific article published on 01 April 2011

Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis

scientific article published on 13 October 2020

Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial

scientific article published in June 1998

Alefacept in combination with ultraviolet B phototherapy for the treatment of chronic plaque psoriasis: results from an open-label, multicenter study

scientific article

An Open-label, Observational Study Evaluating Desoximetasone Topical Spray 0.25% in Patients with Scalp Psoriasis.

scientific article published in May 2018

Apremilast and Narrowband Ultraviolet-B Combination Therapy for Treating Moderate-to-Severe Plaque Psoriasis

scientific article published in October 2017

Apremilast with Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis

scientific article published on 01 December 2020

Betamethasone dipropionate spray 0.05% alleviates troublesome symptoms of plaque psoriasis

scientific article published on 01 February 2020

Brodalumab in the treatment of moderate to severe psoriasis in patients when previous anti-interleukin 17A therapies have failed

scientific article published on 10 May 2019

Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis

article published in 2013

Combining Topical Psoriasis Treatment to Enhance Systemic and Phototherapy: A Review of the Literature

scientific article published in December 2017

Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation

scientific article

Consensus guidelines for the management of plaque psoriasis.

scientific article

Decision points for the initiation of systemic treatment for psoriasis

scientific article

Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review

scientific article published on 01 August 2018

Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials

scientific article published on 11 April 2019

Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study

scientific article published on August 2017

Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEIL.

scientific article published in February 2018

Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris--a Randomized Phase III Study (PSO-FAST).

scientific article published on December 2015

Efficacy and Safety of Ixekizumab in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Paediatric Patients with Moderate-to-Severe Plaque Psoriasis (IXORA-PEDS)

scientific article published on 21 April 2020

Enthesitis and Dactylitis in Psoriatic Disease: A Guide for Dermatologists

scientific article published on 01 December 2018

Establishing a practical and effective psoriasis treatment center

scientific article

Evaluation of Patient-Reported Outcomes With Etanercept in Moderate to Severe Plaque Psoriasis Patients After Therapy With Apremilast

scientific article published on 01 April 2020

Evaluation of the Physician Global Assessment and Body Surface Area Composite Tool for Assessing Psoriasis Response to Apremilast Therapy: Results from ESTEEM 1 and ESTEEM 2.

scientific article

From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies

scientific article

From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis

scientific article published on 22 November 2016

From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis.

scientific article published on 5 November 2007

Halobetasol and Tazarotene: Further Defining the Role of a Unique Fixed Combination Topical Lotion in Moderate-to-Severe Plaque Psoriasis

scientific article published on 01 December 2018

Halobetasol propionate for the management of psoriasis

scientific article published on 01 February 2020

Immunogenicity and skin clearance recapture in clinical studies of brodalumab

scientific article published on 05 June 2019

Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials

scientific article published on 22 March 2019

LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone

scientific article published on 01 April 2009

Moderate to severe plaque psoriasis with scalp involvement: a randomized, double-blind, placebo-controlled study of etanercept

scientific article published on October 20, 2011

National Psoriasis Foundation clinical consensus on disease severity

scientific article

Next-generation biologics in the management of plaque psoriasis: a literature review of IL-17 inhibition

scientific article

Open-Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With Apremilast

article by Jerry Bagel et al published 1 October 2018 in Journal of Drugs in Dermatology

Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumab.

scientific article published on 14 February 2017

Optimizing topical therapies for treating psoriasis: a consensus conference

scientific article published on September 1, 2010

Patient‐reported outcomes in moderate‐to‐severe plaque psoriasis with scalp involvement: results from a randomized, double‐blind, placebo‐controlled study of etanercept ⬇️

scientific article published on December 21, 2011

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

scientific article published on October 2015

Phase 3, open-label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate-to-severe plaque psoriasis (UNCOVER-A)

scientific article published on 8 August 2016

Psoriasis Patients on Chronic Biologic Therapy May Benefit from Additional Treatment-Study Design and Baseline Characteristics

scholarly article published on 23 February 2018

Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris

scientific article

Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacy

scientific article published in March 2003

Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 Studies

scientific article published on 01 August 2018

Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials

Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results)

article

Secukinumab maintains superiority over ustekinumab in clearing skin and improving quality of life in patients with moderate to severe plaque psoriasis: 52-week results from a double-blind phase 3b trial (CLARITY)

scientific article published on 04 May 2020

Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologics

scientific article published on 28 November 2019

Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial

scientific article published on 30 January 2020

Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study

scientific article published on 7 October 2015

The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoriasis Vulgaris: Results from the Randomized PSO-FAST Study

scientific article

The National Psoriasis Foundation Psoriasis Treatment Targets in Real World Patients: Prevalence and Association with Patient Reported Outcomes in the Corrona Psoriasis Registry

scientific article published on 06 February 2020

The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study

scientific article published on 2 August 2017

Topical therapies for the treatment of plaque psoriasis.

scientific article published on October 2009

Treat to Target in Psoriasis: A Real-World Experience With Biologics and Adjunctive Topical Therapy

scientific article published on 01 August 2018

Treatment of Medicare Patients with Moderate-to-Severe Psoriasis who Cannot Afford Biologics or Apremilast

scientific article published on 01 February 2020

Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation

scientific article published on January 2009

Treatment with Fixed Combination Calcipotriol 50 ug/g and Betamethasone Dipropionate 0.5 mg/g Foam Provides Rapid and Significant Itch Relief in Patients with Psoriasis

scholarly article published on 23 February 2018

Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes

scientific article published on 01 March 2008

Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy

scientific article published on 30 November 2011

Paulina is supported by:

About Paulina

Help